<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://indianpedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=2405%3A201%3AD002%3A39CC%3ACCB0%3AC992%3A6EB7%3A61C</id>
	<title>IndianPedia - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://indianpedia.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=2405%3A201%3AD002%3A39CC%3ACCB0%3AC992%3A6EB7%3A61C"/>
	<link rel="alternate" type="text/html" href="https://indianpedia.org/wiki/Special:Contributions/2405:201:D002:39CC:CCB0:C992:6EB7:61C"/>
	<updated>2026-07-31T08:57:26Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.45.4</generator>
	<entry>
		<id>https://indianpedia.org/index.php?title=Havells&amp;diff=120498</id>
		<title>Havells</title>
		<link rel="alternate" type="text/html" href="https://indianpedia.org/index.php?title=Havells&amp;diff=120498"/>
		<updated>2021-07-05T07:50:13Z</updated>

		<summary type="html">&lt;p&gt;2405:201:D002:39CC:CCB0:C992:6EB7:61C: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{short description|Indian electrical equipment company}}&lt;br /&gt;
{{Use Indian English|date=May 2019}}&lt;br /&gt;
{{Use dmy dates|date=March 2013}}&lt;br /&gt;
{{Infobox company&lt;br /&gt;
| name                = Havells India Limited&lt;br /&gt;
| logo                = Havells Logo.svg&lt;br /&gt;
| type                = [[Public]]&lt;br /&gt;
| traded_as           = {{BSE|517354}}&amp;lt;br/&amp;gt;{{NSE|HAVELLS}}&lt;br /&gt;
| industry            = [[Electrical equipment]]&lt;br /&gt;
| founder             = [[Qimat Rai Gupta]]&lt;br /&gt;
| key_people          = [[Anil Rai Gupta]] &amp;lt;br /&amp;gt; {{small|(Chairman &amp;amp; [[Managing Director|MD]])}}&amp;lt;ref name=&amp;quot;HavellsAnnualReport&amp;quot;&amp;gt;{{cite web|url=http://www.havells.com/content/dam/havells/annual_reports/2016-2017/Havells%20AR%202016-17.pdf| title=Annual Report 2016-17 | publisher= Havells. | date=6 November 2017 | access-date= 6 November 2017}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| products            = Fast Moving Electrical Goods&lt;br /&gt;
| revenue             = {{decrease}} {{INRConvert|9553|c}} (2020)&amp;lt;ref name=&amp;quot;Financials&amp;quot;&amp;gt;{{cite web|url=https://www.moneycontrol.com/india/stockpricequote/electricequipment/havellsindia/HI01|title=Havells India Ltd. Financial Statements |website=moneycontrol.com}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| operating_income    = {{decrease}} {{INRConvert|924|c}} (2020)&amp;lt;ref name=&amp;quot;Financials&amp;quot;/&amp;gt;&lt;br /&gt;
| net_income          = {{decrease}} {{INRConvert|735|c}} (2020)&amp;lt;ref name=&amp;quot;Financials&amp;quot;/&amp;gt;&lt;br /&gt;
| assets              = {{decrease}} {{INRConvert|7073|c}} (2020)&amp;lt;ref name=&amp;quot;Financials&amp;quot;/&amp;gt;&lt;br /&gt;
| equity              = {{decrease}} {{INRConvert|4248|c}} (2020)&amp;lt;ref name=&amp;quot;Financials&amp;quot;/&amp;gt;&lt;br /&gt;
| num_employees       = 5,781 (2020)&amp;lt;ref name=&amp;quot;Financials&amp;quot;/&amp;gt;&lt;br /&gt;
| divisions           = {{plainlist| &lt;br /&gt;
*[[Electric motor|LV Motor]]s&lt;br /&gt;
*[[Home appliance|Home applications]] &lt;br /&gt;
*[[List of cooking appliances|Kitchen Appliances]]&lt;br /&gt;
*[[Lighting]]&lt;br /&gt;
*[[Switchgear|Consumer and Industrial Switchgear]] &lt;br /&gt;
*[[Electrical cable|Cables]] and [[Wire]]s&lt;br /&gt;
*[[Electrical equipment]]}}&lt;br /&gt;
| website             = {{URL|www.havells.com}}&lt;br /&gt;
| foundation          = 1958&amp;lt;ref&amp;gt;{{cite web|url=http://www.havells.com/en/aboutus/Milestones.html|title=1958|access-date=19 May 2016}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| location            = [[Noida]], [[Uttar Pradesh]], [[India]]&lt;br /&gt;
| area_served         = Worldwide&lt;br /&gt;
}}&lt;br /&gt;
&#039;&#039;&#039;Havells India Limited&#039;&#039;&#039; is an Indian [[electrical equipment]] company based in [[Noida]]. In business since 1958, the company has products ranging from home and kitchen appliances, lighting for domestic, commercial and industrial applications, [[LED lighting]], [[fan (machine)|fans]], modular switches and wiring accessories, [[water heater]]s, industrial and domestic circuit protection switchgear, industrial and domestic [[Electrical cable|cable]]s and [[wire]]s, [[induction motor]]s, and [[capacitor]]s among others.&lt;br /&gt;
Havells India owns some brands like Havells, Lloyd, Crabtree, Standard Electric, Reo and Promptech. &lt;br /&gt;
&lt;br /&gt;
The company has 23 branches / representative offices with over 6,000 workers in over 50 countries. India&#039;s first Lloyd&#039;s exclusive outlet is acquired by businessman Mr. Rajan Bansal. The store is situated in western part of New Delhi, Paschim Vihar.&amp;lt;ref&amp;gt;{{cite web|last=Review|first=Engineering|title=Havells Industrial on an overdrive and launches a product lounge on wheels}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{cite web|url=http://www.havells.com/en/aboutus.html|title=^|access-date=19 May 2016}}&amp;lt;/ref&amp;gt; As of 2016, it has 11 manufacturing plants in [[India]] located at [[Haridwar]], [[Baddi]], [[Noida]], [[Faridabad]], [[Alwar]], [[Neemrana]], and [[Bengaluru]].&amp;lt;ref&amp;gt;{{cite web|last=Singh|first=A|title=Havells {{!}} Press Kit|url=http://www.havells.com/en/press-release/media-kit.html|work=www.havells.com|publisher=Havells India Ltd|access-date=1 November 2013}}&amp;lt;/ref&amp;gt; In 2014, Havells was listed 125th among 1200 of India&#039;s most trusted brands according to the [[The Brand Trust Report|Brand Trust Report]] 2014, a study conducted by Trust Research Advisory.&amp;lt;ref&amp;gt;{{Cite web|url = http://www.trustadvisory.info/pdf/BTR2015_categorywise.compressed.pdf|title = India&#039;s Most Trusted Brands 2014}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- Deleted image removed: [[File:Havells office old.jpg|right|210px|thumb|Havells in the year 1976]] --&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Establishment and early history===&lt;br /&gt;
&lt;br /&gt;
In 1958, [[Qimat Rai Gupta]] dropped out of school and founded an electric trading operation in the electric wholesale market of [[Old Delhi]]. With an investment of Rs.10,000, he started Havell&#039;s Industries.&amp;lt;ref&amp;gt;{{cite web|last=Mark|first=Ezine|title=Havells|url=http://www.havells.com/en/aboutus/Milestones.html}}&amp;lt;/ref&amp;gt; In 1971, Gupta bought Havells brand from Haveli Ram Gandhi, and in next five years he started the first manufacturing plant at Tilak Nagar, [[New Delhi]] of the Rewireable Switches and Changeover Switches in his Kirti Nagar Plant, near [[New Delhi]]. In next few years, Havells started to set up manufacturing of the energy metres. Later, it acquired Towers and Transformers Ltd. and turned it into a profitable manufacturing energy meters company in one year.{{citation needed|date=January 2012}} Later, the company entered MCBs manufacturing at Badli, Delhi, in a joint venture with [[Geyer]], [[Germany]].&lt;br /&gt;
&lt;br /&gt;
In 1974, the company started manufacturing of the Changeover Switches plant at [[Sahibabad]], [[Uttar Pradesh]]. In 1980, they started manufacturing Control Gear Products at their [[Faridabad]], [[Haryana]] plants. Later in the 1980s, they acquired a manufacturing plant at [[Alwar]], [[Rajasthan]] for Power Cables &amp;amp; Wires. In that same year, they entered into a joint venture with [[Electrium]], UK for manufacturing Dorman Smith MCCB and Crabtree modular plate switches. Acquired an electric control and switchboards at [[Noida]] for manufacturing customised packaged [[solution]]s. Introduced high-end Ferraris Meters in joint venture with DZG, Germany. Acquired controlling stake in Duke Arnics Electronics (P) Limited engaged in manufacturing of electronic metres—single-phase, three-phase, multi-function, tri-vectors and also acquired controlling interest in an industry major-Standard Electricals Ltd and also an acquired business of Havells Industries Ltd, MCCB of Crabtree India Limited and merged ECS Limited in the company to consolidate its area of core competence.&lt;br /&gt;
&lt;br /&gt;
===Global presence===&lt;br /&gt;
&lt;br /&gt;
In late 1990s, Standard Electrical Company became a 100% subsidiary of the company. The company gained IEC certification for industrial switchgear and CSA certification for all manufacturing plants in 1991.{{Citation needed|date=April 2012}} Soon production started in their plant located at [[Baddi]], [[Himachal Pradesh]] for manufacturing domestic switchgear. Setting up a manufacturing plant for manufacturing of ceiling fans at [[Noida]], [[Uttar Pradesh]].&lt;br /&gt;
&lt;br /&gt;
In 1999, Havell&#039;s opened their first international sales office in [[London]] through their wholly owned subsidiary company Havells U.K. Ltd. In December 2004, placed 235 fully convertible debentures of Rs.1&amp;amp;nbsp;[[lakh]] on M/s. Shine Ltd., [[Mauritius]] and the debenture were converted in June 2006. Attained the CE certificate for CFLs. In March 2005, Havells Started the manufacturing of the Electric Fans at its plant located near [[Haridwar]], [[Uttarakhand]] and got an award for the KEMA certification by The Dutch Council for Accreditation, making QRG the only group to attain this certification in India.{{citation needed|date=January 2012}} The company started their first R&amp;amp;D Centre in [[Noida]]. In November 2005, Crabtree India merged with Havells [[India]] adding a CFL production unit in [[Haridwar]] manufacturing plant.&lt;br /&gt;
&lt;br /&gt;
Expansion at [[Alwar]] manufacturing plant for an increase of production capacity and another expansion at the Baddi manufacturing plant and set-up of an Export Oriented Unit started in that same year. In 2006, it became one of India&#039;s first companies to get the [[ISI mark]] Certification from the [[Bureau of Indian Standards]] for a complete range of CFLs. The company is setting up new fully automatic water heater manufacturing plant in [[Neemrana]], [[Rajasthan]].&lt;br /&gt;
&lt;br /&gt;
===Expansion era===&lt;br /&gt;
&lt;br /&gt;
In 2007, Havells&#039; creation of a capacitor manufacturing plant in [[Noida]], [[Uttar Pradesh]] with the capacity of 6,00,000 KVAr per month was completed. Later it acquired the lighting business of a [[Frankfurt]] based company [[Sylvania Electric Products|Sylvania]], a global leader in the lighting business and now for the first time in its history, the company&#039;s turnover exceeded US$1 billion. By 2007, Havell&#039;s were well known for its electrical switches, energy meters and miniature circuit breakers (MCBs). In March 2007, Havells acquired SLI Sylvania of [[Netherlands]] for $300 million, making it the fourth largest lighting business in the world, worth over a billion USD.{{Citation needed|date=April 2012}} This was, at that time, the biggest overseas takeover by an Indian electrical equipment manufacturer. This takeover helped to give the Havells brand access to over 20,000 dealers across Latin America, Europe, Asia and Africa. The combined Havells-Sylvania generated over a $1 billion in revenue with more than 60% coming from international sales.&lt;br /&gt;
&lt;br /&gt;
Due to past mergers, Havells’ portfolio includes many well-known brands like Crabtree, Sylvania, Concord, Luminance, Linolite &amp;amp; SLI Lighting. In 2008, it became one of the first Indian CFL manufacturers to have adopted RoHS, European norms on the restriction of hazardous substances in CFLs. In October 2008, Havell&#039;s moved to its new corporate headquarters, QRG Towers located in [[Noida]]. With an investment of Rs. 50&amp;amp;nbsp;[[crore]] in Global Centre for Research and Innovation (CRI) construction of a fully automatic plant for Havells Lafert Motors at Neemrana also started in that same year. In 2010, it acquired 100% interest in Standard Electricals to set up the world&#039;s first new generation CMH lamp plant at [[Neemrana]]. In 2012, Indian actor [[Rajesh Khanna]] endorsed Havells Fan TVC titled Havells Fans Forever.&lt;br /&gt;
&lt;br /&gt;
In September 2013, Havells launched domestic pumps for the Indian market. Initially, the company plans to launch the monoblock pumps and expand the product range gradually. Monoblock pumps of Havells are being manufactured at Neemrana Motor factory using the production capacity of the unit. &lt;br /&gt;
&amp;lt;ref&amp;gt;{{cite news| url=http://economictimes.indiatimes.com/industry/cons-products/electronics/havells-india-eyes-acquisitions-in-china-asean-latin-america/articleshow/5607993.cms | title=Havells India looks for acquisitions in China, Africa | date=11 June 2012 | work=The Times Of India}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Sylvania Divestment===&lt;br /&gt;
&lt;br /&gt;
In December 2015, Havells India Ltd. sold 80% stake in Sylvania Malta, and Havells Exim Hong Kong to Shanghai Feilo Acoustics for Rs 1,100 crore. Havells had invested Rs 980 crore in both the subsidiaries.&lt;br /&gt;
&lt;br /&gt;
==Products==&lt;br /&gt;
&lt;br /&gt;
* Building Circuit Protection&lt;br /&gt;
* Miniature Circuit Breaker&lt;br /&gt;
* Industrial Circuit Protection&lt;br /&gt;
* Motors&lt;br /&gt;
* Professional and Consumer Lighting&lt;br /&gt;
* LED Lights and Bulbs&lt;br /&gt;
* Small Domestic Appliances&lt;br /&gt;
* Air Purifiers&lt;br /&gt;
* Air Coolers&lt;br /&gt;
* Capacitors&lt;br /&gt;
* Ceiling Fans, Table Fans, Pedestal Fans, Wall Fans, Exhaust Fans&lt;br /&gt;
* Water Heaters&lt;br /&gt;
* Water Purifiers&lt;br /&gt;
* Domestic Water Pumps&lt;br /&gt;
* Electrical Wire Accessories&lt;br /&gt;
* Personal Grooming Equipment&#039;s&lt;br /&gt;
&lt;br /&gt;
==Stock market==&lt;br /&gt;
&lt;br /&gt;
Market Capital of Havells is 38,158 Crores (as of 8 August 2020). The shares of Havells are listed in [[Bombay Stock Exchange]] in &#039;A&#039; category and is included in S&amp;amp;P BSE 200 Group. Promoters hold a 61% stake in the company followed by 23% FIIs. During 2011–14, the stock gave more than 300% return following its exceptional growth. Havells&#039; major peers includes Crompton Greaves and Orient Electric.&amp;lt;ref&amp;gt;{{cite web|title=Havells India Stock Price|url=http://www.moneycontrol.com/india/stockpricequote/electric-equipment/havellsindia/HI01|website=www.moneycontrol.com|access-date=6 November 2015}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Marketing==&lt;br /&gt;
&lt;br /&gt;
The company has promoted its brand through sponsorship of [[cricket]] events like Champions Trophy, Champions League, [[Indian Premier League|IPL]] Season 2, IPL Season 1, T20 World Cup.{{citation needed|date=February 2011}} The company also reaches consumers directly, through &amp;quot;Havells Galaxy&amp;quot; – a shop for electrical and lighting needs.&lt;br /&gt;
&lt;br /&gt;
==Acquisitions==&lt;br /&gt;
In 1983, it bought the loss-making Delhi-based Towers and Transformers Ltd and turned it around in a year. Between 1997 and 2001, Havells also bought ECS, Duke Arnics Electronics, Standard Electricals and Crabtree India. There was a 50:50 joint venture between Havells and the UK-based Crabtree, and Havells later acquired Crabtree&#039;s stake in the JV.&amp;lt;ref&amp;gt;{{cite web|url=http://www.businesstoday.in/magazine/case-study/smart-turnaround-strategy-helped-havells/story/197235.html|title=How a smart turnaround strategy helped Havells to make a comeback|access-date=19 May 2016}}&amp;lt;/ref&amp;gt; The latest acquisition of [[Lloyd Electricals]] has marked its entry in new segments of consumer electronics.&lt;br /&gt;
&lt;br /&gt;
==Social initiatives==&lt;br /&gt;
&lt;br /&gt;
Havells provides mid day meal for school children in [[Alwar district]], covering 50,000 students per day.&amp;lt;ref&amp;gt;{{cite news|last=Times|first=Economic|title=Havells India Ltd.|url=http://economictimes.indiatimes.com/havells-india-ltd/directorsreport/companyid-10507.cms|work=The Times of India}}&amp;lt;/ref&amp;gt; This has greatly increased the number of children attending school regularly and also alleviates hunger.&amp;lt;ref name=&amp;quot;karmayog1&amp;quot;&amp;gt;{{cite web|last=yog|first=Karma|title=Havells India Ltd. – Corporate Social Responsibility Activities are as follows|url=http://www.karmayog.org/csr1to500/csr1to500_20134.htm}}&amp;lt;/ref&amp;gt; Besides this the company has acquired land for constructing a larger kitchen with all the modern facilities to serve freshly cooked food to 50,000 students in the area.&amp;lt;ref name=&amp;quot;karmayog1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The group company, QRG Healthcare runs a 140-bed hospital in [[Faridabad]]. In the past, the company has generously contributed to the society during various natural calamities like the Bihar Flood, Tsunami and Kargil National Relief Fund, etc.&amp;lt;ref name=&amp;quot;havells.com&amp;quot;&amp;gt;[http://www.havells.com/en/aboutus.html About the company]&amp;lt;/ref&amp;gt; Havells runs a mobile Medical Van, equipped with a trained doctor and necessary medicines in the rural areas of [[Delhi]] and [[National Capital Region (India)|NCR]] for the very poor and needy villagers. The company also set up free medical check-up camps.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
{{Template:Nifty 200 companies}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Companies listed on the Bombay Stock Exchange]]&lt;br /&gt;
[[Category:Electrical wiring and construction supplies manufacturers]]&lt;br /&gt;
[[Category:Electrical equipment manufacturers]]&lt;br /&gt;
[[Category:Manufacturing companies based in Noida]]&lt;br /&gt;
[[Category:Electronics companies established in 1958]]&lt;br /&gt;
[[Category:Electrical engineering companies of India]]&lt;br /&gt;
[[Category:1958 establishments in Uttar Pradesh]]&lt;br /&gt;
[[Category:Wire and cable manufacturers]]&lt;br /&gt;
[[Category:Indian brands]]&lt;/div&gt;</summary>
		<author><name>2405:201:D002:39CC:CCB0:C992:6EB7:61C</name></author>
	</entry>
	<entry>
		<id>https://indianpedia.org/index.php?title=Biocon&amp;diff=109628</id>
		<title>Biocon</title>
		<link rel="alternate" type="text/html" href="https://indianpedia.org/index.php?title=Biocon&amp;diff=109628"/>
		<updated>2021-07-05T07:42:37Z</updated>

		<summary type="html">&lt;p&gt;2405:201:D002:39CC:CCB0:C992:6EB7:61C: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Short description|Indian multinational biopharmaceutical company}}&lt;br /&gt;
{{multiple issues|&lt;br /&gt;
{{advert|date=April 2012}}&lt;br /&gt;
{{COI|date=May 2016}}&lt;br /&gt;
{{cleanup reorganize|date=May 2016}}&lt;br /&gt;
{{more citations needed|date=May 2016}}&lt;br /&gt;
}}&lt;br /&gt;
{{Use Indian English|date=December 2020}}&lt;br /&gt;
{{Use dmy dates|date=September 2020}}&lt;br /&gt;
&lt;br /&gt;
{{Infobox company&lt;br /&gt;
| name = Biocon Limited&lt;br /&gt;
| logo = Biocon Logo.svg&lt;br /&gt;
| type = [[Public company|Public]]&lt;br /&gt;
| traded_as = {{BSE|532523}} &amp;lt;br /&amp;gt; {{NSE|BIOCON}}&lt;br /&gt;
| founder = [[Kiran Mazumdar-Shaw]]&lt;br /&gt;
| key_people = [[Kiran Mazumdar-Shaw]]&amp;lt;small&amp;gt;&amp;lt;br /&amp;gt;(Chairperson &amp;amp; MD)&amp;lt;/small&amp;gt;&amp;lt;br /&amp;gt;&lt;br /&gt;
Siddharth mittal&amp;lt;small&amp;gt;&amp;lt;br /&amp;gt;(CEO &amp;amp; Joint Managing Director)&amp;lt;/small&amp;gt;&amp;lt;br /&amp;gt;&lt;br /&gt;
| ISIN = INE376G01013&lt;br /&gt;
| industry = [[Biopharmaceutical]]&lt;br /&gt;
| products = [[Biologics]] &amp;lt;br /&amp;gt; Small Molecules &amp;lt;br /&amp;gt; Branded Formulations &amp;lt;br /&amp;gt; Research Services&lt;br /&gt;
| services = &lt;br /&gt;
| revenue = {{Increase}} {{INRConvert|6528.60|c}} &amp;lt;ref name=pls&amp;gt;{{Cite web|title=Biocon Consolidated Profit &amp;amp; Loss account, Biocon Financial Statement &amp;amp; Accounts|url=https://www.moneycontrol.com/financials/biocon/consolidated-profit-lossVI/bl03|access-date=31 July 2020|website=www.moneycontrol.com|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| revenue_year = 2020&lt;br /&gt;
| operating_income = {{Increase}} {{INRConvert|1214.90|c}} &amp;lt;ref name=pls/&amp;gt;&lt;br /&gt;
| income_year = 2020&lt;br /&gt;
| net_income = {{Decrease}} {{INRConvert|748.20|c}} &amp;lt;ref name=pls/&amp;gt;&lt;br /&gt;
| net_income_year = 2020&lt;br /&gt;
| assets = {{Increase}} {{INRConvert|14443.80|c}} &amp;lt;ref name=bls&amp;gt;{{Cite web|title=Biocon Consolidated Balance Sheet, Biocon Financial Statement &amp;amp; Accounts|url=https://www.moneycontrol.com/financials/biocon/consolidated-balance-sheetVI/bl03|access-date=31 July 2020|website=www.moneycontrol.com|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| assets_year = 2020&lt;br /&gt;
| equity = {{Increase}} {{INRConvert|6705.80|c}} &amp;lt;ref name=bls/&amp;gt;&lt;br /&gt;
| equity_year = 2020&lt;br /&gt;
| num_employees = 9,234 &amp;lt;small&amp;gt;(Mar 2017)&amp;lt;/small&amp;gt;&amp;lt;ref name=&amp;quot;biocon2017&amp;quot;&amp;gt;{{cite web|url=http://www.biocon.com/docs/Biocon_Annual_Report_2017.pdf|title=Biocon Annual Report 2017|publisher=Biocon}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| subsid = Syngene &amp;lt;br /&amp;gt;&lt;br /&gt;
| intl = &lt;br /&gt;
| foundation = {{Start date and age|1978|p=y}}&lt;br /&gt;
| slogan = &lt;br /&gt;
| location_city = [[Bangalore, Karnataka]]&lt;br /&gt;
| location_country = [[India]]&lt;br /&gt;
| homepage = {{URL|www.biocon.com}}&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Biocon Limited&#039;&#039;&#039; is an Indian [[biopharmaceutical]] company based in [[Bangalore]], [[India]] founded by Kiran Mazumdar-Shaw.&amp;lt;ref name=&amp;quot;ref1&amp;quot; /&amp;gt; The company manufactures [[Generic drug|generic]] active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe,{{citation needed|date=September 2020}} including the developed markets of the United States and Europe.&amp;lt;ref name=&amp;quot;ref1&amp;quot; /&amp;gt; It also manufactures novel biologics, as well as, [[biosimilar insulins]] and antibodies, which are sold in India as branded formulations. Biocon&#039;s biosimilar products are also sold in both bulk and formulation forms in several emerging markets.{{citation needed|date=March 2021}} In contract research services, &#039;&#039;&#039;Syngene International Limited&#039;&#039;&#039; (Syngene), a publicly listed subsidiary of Biocon.&lt;br /&gt;
&lt;br /&gt;
Biocon&#039;s formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon&#039;s key brands in India include INSUGEN (rh-insulin), BASALOG (Glargine), BIOMAb EGFR (Nimotuzumab), BLISTO (Glimepiride + Metformin), CANMAb (Trastuzumab), Evertor (Everolimus), TACROGRAF (Tacrolimus), ALZUMAb(Itolizumab) and KRABEVA (Bevacizumab).&amp;lt;ref name=&amp;quot;ref1&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Biocon and Syngene together employ about 9200 personnel.&amp;lt;ref name=&amp;quot;ref1&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
Biocon was founded in 1978 with Rs. 10,000 as the initial capital.&amp;lt;ref&amp;gt;{{Cite web|last=Egan|first=Mary Ellen|title=Big Shot in Bangalore|url=https://www.forbes.com/forbes/2004/1018/088.html|access-date=2021-03-07|website=Forbes|language=en}}&lt;br /&gt;
&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 1979 - Becomes the first Indian company to manufacture and export enzymes to USA and Europe.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.indianmirror.com/indian-industries/top-industries/biocon.html|title=Biocon, India&#039;s largest biotech company.|last=nimmi|website=www.indianmirror.com|language=en-US|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 1989 - [[Unilever]] acquires Biocon Biochemicals Ltd. in Ireland and merges it with its subsidiary, Quest International; Biocon receives US funding for proprietary technologies.&amp;lt;ref name=&amp;quot;ref8&amp;quot; /&amp;gt;&lt;br /&gt;
* 1994 - Establishes [http://www.syngeneintl.com/ Syngene International Pvt. Ltd]. as a Custom Research Company (CRC).&amp;lt;ref name=&amp;quot;ref8&amp;quot; /&amp;gt;&lt;br /&gt;
* 1998 - Unilever agrees to sell its shareholding in Biocon to the Indian promoters. Biocon becomes an independent entity.&amp;lt;ref&amp;gt;{{Cite book|url=https://books.google.com/books?id=a9WGAwAAQBAJ&amp;amp;q=1998%E2%80%94Unilever+agrees+to+sell+its+shareholding+in+Biocon+to+the+Indian+promoters.+Biocon+becomes+an+independent+entity&amp;amp;pg=PA214|title=Winning Strategies for Business|last=Baisya|first=Rajat K.|date=9 September 2010|publisher=SAGE Publications India|isbn=9788132106081|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2001 - Becomes the first Indian company to be approved by [[Food and Drug Administration|USFDA]] for the manufacture of [[lovastatin]]; PlaFractor is granted a US 2001 and worldwide patent.&amp;lt;ref&amp;gt;{{Cite book|url=https://books.google.com/books?id=az8D9OOvfF0C&amp;amp;q=biocon+Becomes+the+first+Indian+company+to+be+approved+by+USFDA+for+the+manufacture+of+lovastatin&amp;amp;pg=PA654|title=Strategic Management 10E|last=Pearce|date=2009|publisher=McGraw-Hill Education (India) Pvt Limited|isbn=9780070264380|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2003 - Biocon becomes the first company worldwide to develop human insulin on a [[Pichia pastoris|Pichia]] expression system.&amp;lt;ref&amp;gt;{{Cite web|url=https://www.brandindiapharma.in/pharmaceutical-companies-india/biocon-limited|title=Biocon Ltd: About Biocon Pharma Company Founder, CEO, Products &amp;amp; Contact Address|website=www.brandindiapharma.in|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2006 -  BIOMAb EGFR, first indigenously developed humanised monoclonal antibody for head-and-neck cancer is launched and [[A. P. J. Abdul Kalam|Dr. APJ Abdul Kalam]] inaugurates India&#039;s Largest Biotech-Hub &amp;quot;Biocon Park&amp;quot;.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&amp;amp;id=95300|title=Dr. APJ Abdul Kalam Dedicates India\&#039;s First Cancer Drug BIOMab EGFR to the Nation and Inaugurates India\&#039;s Largest Biotech-Hub &amp;quot;Biocon Park&amp;quot; {{!}} Evaluate|website=www.evaluategroup.com|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* * 2008 - Biocon acquires a 70% stake in German pharmaceutical company, AxiCorp GmbH.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&amp;amp;id=149061&amp;amp;sectionID=&amp;amp;isEPVantage=no|title=Biocon Acquires 70% Stake in German Pharmaceutical Company, AxiCorp: Biosimilars Will be Main Focus {{!}} Evaluate|website=www.evaluategroup.com|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2009 - Syngene-[[Bristol-Myers Squibb|Bristol Myers Squibb]] research facility is established in Bengaluru.&amp;lt;ref&amp;gt;{{Cite book|url=https://books.google.com/books?id=aoHRAwAAQBAJ&amp;amp;q=syngene+bms+partnership+2009&amp;amp;pg=PA451|title=India&#039;s Healthcare Industry: Innovation in Delivery, Financing, and Manufacturing|last=Burns|first=Lawton R.|date=13 January 2014|publisher=Cambridge University Press|isbn=9781107044371|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2009 - [[Mylan]] announces strategic collaboration with Biocon to Enter the Global Generic Biologics Market.&amp;lt;ref&amp;gt;{{Cite news|url=http://newsroom.mylan.com/press-releases?item=122588|title=Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market|work=MediaRoom|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2010 - Biocon expands to Malaysia, biopharmaceutical manufacturing and R&amp;amp;D facility established in [[Iskandar]] Malaysia, [[Johor]].&amp;lt;ref&amp;gt;{{Cite news|url=https://www.asianscientist.com/2011/09/pharma/biocon-limited-rnd-facility-bio-xcell-malaysia/|title=Biocon Limited To Build US$161 Million R&amp;amp;D Facility in Bio-XCell, Malaysia|date=11 September 2011|work=Asian Scientist Magazine {{!}} Science, technology and medical news updates from Asia|access-date=8 February 2018|language=en-US}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2011 - Biocon launches INSUPen®, a convenient and affordable reusable insulin delivery device.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.evaluategroup.com/Universal/View.aspx?type=Story&amp;amp;id=259989|title=Biocon Launches INSUPen®, a Convenient and Affordable Reusable Insulin Delivery Device {{!}} Evaluate|website=www.evaluategroup.com|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2012 - [[Abbott Laboratories|Abbott]] announces collaboration with Syngene to Open First Nutrition R&amp;amp;D Center in India.&amp;lt;ref&amp;gt;{{Cite web|url=https://www.prnewswire.com/news-releases/abbott-announces-collaboration-with-syngene-to-open-first-nutrition-rd-center-in-india-149948055.html|title=Abbott Announces Collaboration with Syngene to Open First Nutrition R&amp;amp;D Center in India|last=Abbott|website=prnewswire.com|language=en|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2013 - Biocon launches biologic drug ALZUMAb to treat [[psoriasis]].&amp;lt;ref&amp;gt;{{Cite news|url=http://www.thehindubusinessline.com/companies/Biocon-unveils-biologic-drug-to-treat-skin-disorder/article20647520.ece|title=Biocon unveils biologic drug to treat skin disorder|work=@businessline|access-date=8 February 2018|language=en}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2014 - Biocon launches world&#039;s first biosimilar drug CANMAb to treat [[breast cancer]].&amp;lt;ref&amp;gt;{{cite web|url=http://timesofindia.indiatimes.com/business/india-business/Kiran-Mazumdar-Shaws-Biocon-develops-new-breast-cancer-drug/articleshow/29016754.cms |title=Kiran Mazumdar-Shaw&#039;s Biocon develops new breast cancer drug |publisher=indiatimes.com |date=18 January 2014 |access-date=19 January 2014}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2015 - Biocon launches [[hepatitis-C]] drug in India under brand name CIMIVIR-L.&amp;lt;ref&amp;gt;{{Cite news|url=http://www.livemint.com/Companies/78WwKeykyzx3G5X4AhcQKJ/Biocon-launches-hepatitisC-drug-in-India.html|title=Biocon launches hepatitis-C drug in India|last=Pilla|first=Viswanath|date=24 December 2015|work=livemint.com/|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2016 - Becomes the first Indian company to launch a [[biosimilar]] [[Insulin glargine|Insulin Glargine]] pen in Japan.&amp;lt;ref&amp;gt;{{Cite news|url=http://www.livemint.com/Companies/T3byt5dkq71gZoWez8fhRL/Biocons-partner-FUJIFILM-launches-insulin-glargine-in-Japan.html|title=Biocon&#039;s partner FUJIFILM launches insulin glargine in Japan|last=Pilla|first=Viswanath|date=15 July 2016|work=livemint.com/|access-date=20 December 2017}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2016 - Syngene sets up [[Amgen]] R&amp;amp;D center in Bangalore.&amp;lt;ref&amp;gt;{{Cite web|url=https://www.fiercebiotech.com/cro/indian-cro-syngene-sets-up-amgen-r-d-center-bangalore|title=Indian CRO Syngene sets up Amgen R&amp;amp;D center in Bangalore {{!}} FierceBiotech|website=www.fiercebiotech.com|language=en|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2017 - Biocon&#039;s Insugen is the first locally manufactured biosimilar product to be approved for sale by the Malaysian drug regulator.&amp;lt;ref&amp;gt;{{Cite web|url=https://www.biosimilardevelopment.com/doc/biocon-wins-myr-million-contract-for-insulin-from-moh-malaysia-0001|title=Biocon Wins MYR 300 Million Contract For Insulin From MoH Malaysia|website=www.biosimilardevelopment.com|language=en|access-date=20 December 2017}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2017 - USFDA approves [[Mylan]]-Biocon&#039;s biosimilar for cancer drug [[Trastuzumab|Herceptin]].&amp;lt;ref&amp;gt;{{Cite news|url=http://www.livemint.com/Industry/AdFKCQcZvRRXnToosfdMbO/US-FDA-approves-MylanBiocons-biosimilar-for-cancer-drug-He.html|title=US FDA approves Mylan-Biocon&#039;s biosimilar for cancer drug Herceptin|last=Trivedi|first=Isha|date=2 December 2017|work=livemint.com/|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* 2018 - Biocon, Mylan get European Commission approval to market biosimilar insulin glargine.&amp;lt;ref&amp;gt;{{cite news |title=Biocon, Mylan get European Commission approval to market biosimilar insulin glargine|url=https://business.medicaldialogues.in/biocon-mylan-get-european-commission-approval-market-biosimilar-insulin-glargine/ |publisher= Business Medical Dialogues|date=30 March 2018 }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Corporate governance==&lt;br /&gt;
[[File:STR 6036.jpg|thumb|Kiran Mazumdar-Shaw is an Indian entrepreneur. She founded Biocon in 1978.]]&lt;br /&gt;
Biocon&#039;s CMD [[Kiran Mazumdar-Shaw|Kiran Mazumdar–Shaw]] joined Biocon in 1978.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;ref13&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;ref14&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Her efforts in biotechnology have drawn global recognition both for the industry in India and for Biocon and she has been called India&#039;s &#039;biotech queen&#039; by [[The Economist]]&amp;lt;ref name=&amp;quot;ref15&amp;quot;/&amp;gt; and India&#039;s &#039;mother of invention&#039; by [[The New York Times]].&amp;lt;ref name=&amp;quot;ref16&amp;quot;/&amp;gt; She was recently named{{when|date=March 2021}} among [[Time (magazine)|TIME]] magazine&#039;s 100 most influential people in the world based not only on her contribution to the biotech industry but also because she gives back to the community.&amp;lt;ref name=&amp;quot;ref17&amp;quot;/&amp;gt; Ms Shaw features on the [[Forbes]] list of ‘The World’s 100 Most Powerful Women’&amp;lt;ref name=&amp;quot;ref18&amp;quot;/&amp;gt; and in [[Financial Times]]’ ‘Top 50 Women in Business’ list&amp;lt;ref name=&amp;quot;ref19&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Shaw is the recipient of several awards including the [[Nikkei Asia Prize]], 2009 for Regional Growth,&amp;lt;ref name=&amp;quot;ref21&amp;quot;/&amp;gt; Express Pharmaceutical Leadership Summit Award 2009 for Dynamic Entrepreneur, [[The Economic Times]] ‘Businesswoman of the Year’, the ‘[[Veuve Clicquot]] Initiative For Economic Development For Asia, [[Ernst &amp;amp; Young]]’s Entrepreneur of the Year Award for Life Sciences &amp;amp; Healthcare, ‘Technology Pioneer’ recognition by World Economic Forum and The Indian Chamber of Commerce Lifetime Achievement Award. She has received two Indian national awards—[[Padma Shri]] (1989) and [[Padma Bhushan]] (2005) for her pioneering efforts in Industrial Biotechnology.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Biocon announced that Dr. Christiane Hamacher has been appointed as the CEO of Biocon Biologic India Limited, with her term having started in March 2019.&amp;lt;ref&amp;gt;{{cite news|url=https://business.medicaldialogues.in/biocon-appoints-christiane-hamacher-as-ceo-of-biocon-biologics-india/|title=Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India|date=2 March 2019|work=Medical Dialogues}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
On 3 December 2019, Siddharth Mittal took over from Dr. Arun Chandavarkar who retired as [[Chief Executive Officer|CEO]] &amp;amp; Joint Managing Director of Biocon.&amp;lt;ref&amp;gt;{{cite news|date=3 December 2019|title=Biocon names Siddharth Mittal as new CEO, Joint MD; bids farewell to Arun Chandavarkar|publisher=Medical Dialogues|url=https://business.medicaldialogues.in/biocon-names-siddharth-mittal-as-new-ceo-joint-md-bids-farewell-to-arun-chandavarkar/}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Subsidiaries==&lt;br /&gt;
&lt;br /&gt;
===Syngene International Ltd===&lt;br /&gt;
&lt;br /&gt;
Established in 1993, Syngene International Limited is Biocon&#039;s custom research organisation offering pharmaceutical and biotechnology majors customized solutions in synthetic chemistry and molecular biology for early-stage drug discovery and development.{{citation needed|date=March 2021|reason=date, need to cite}}&lt;br /&gt;
&lt;br /&gt;
===Clinigene===&lt;br /&gt;
&lt;br /&gt;
Clinigene International Limited is a subsidiary on Syngene offering international pharmaceutical majors Phase I-IV clinical trials and studies for novel/generic molecules.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===BBPL===&lt;br /&gt;
&lt;br /&gt;
Biocon established Biocon Biopharmaceuticals Pvt. Ltd. (BBPL) in 2003 as a joint venture with the Cuban institute CIMAB to develop and market a range of MAbs and cancer vaccines.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biocon-AxiCorp===&lt;br /&gt;
&lt;br /&gt;
In 2008, Biocon acquired a majority stake of 70% in AxiCorp GmbH, a German pharmaceutical marketing company.{{citation needed|date=March 2021|reason=statistic/date, need to cite}}&lt;br /&gt;
&lt;br /&gt;
===NeoBiocon===&lt;br /&gt;
&lt;br /&gt;
Incorporated in January 2008, NeoBiocon FZ LLC is a research and marketing pharmaceutical company based in [[Abu Dhabi]].{{citation needed|date=March 2021|reason=date, need to cite}}&lt;br /&gt;
&lt;br /&gt;
===Biofusion Therapeutics Limited===&lt;br /&gt;
&lt;br /&gt;
Incorporated in March of 2021, 100% owned by Biocon.&lt;br /&gt;
&lt;br /&gt;
==Strategic Partnerships==&lt;br /&gt;
===Biocon and Amylin===&lt;br /&gt;
&lt;br /&gt;
In 2009, Biocon and Amylin Pharmaceuticals of the United States entered into an agreement to develop, commercialise and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin provides expertise in peptide hormone development, particularly in the area of phybrid technology and metabolic disease therapeutics. Biocon will utilise its expertise in recombinant microbial expression and experience in preclinical and clinical development of diabetes products to manufacture the compound.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biocon and IATRICa===&lt;br /&gt;
&lt;br /&gt;
In 2008, Biocon and IATRICa of the United States announced a strategic partnership to co-develop immunoconjugates for targeted immunotherapy of cancers and infectious diseases. The companies are co-developing candidate products based upon IATRICa&#039;s technology platform and Biocon&#039;s expertise in drug development, biologics manufacturing, and clinical research. The goal of this collaboration is to develop a therapeutic vaccine where the T cell mediated immunity is enhanced and maintained against a tumor which otherwise evades immune responses. Methods of developing, characterising and scaling up of conjugated monoclonal antibody production are being currently studied.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biocon and Mylan===&lt;br /&gt;
&lt;br /&gt;
In 2009, Biocon signed a collaboration agreement with Mylan to develop and commercialize generic biologics. Mylan and Biocon will share development, capital and other costs to bring products to market. Mylan will have exclusive commercialisation rights in USA, Canada, Japan, Australia, New Zealand, EU and European Free Trade Association countries through a profit sharing arrangement with Biocon.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biocon and Optimer===&lt;br /&gt;
&lt;br /&gt;
Biocon and Optimer Pharmaceuticals, a biopharmaceutical company focused on the treatment of serious infections such as Clostridium Difficile Infection (CDI), have entered into a long-term supply agreement for the commercial manufacturing of the active pharmaceutical ingredient, fidaxomicin.,&amp;lt;ref name=&amp;quot;ref1&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biocon and Vaccinex===&lt;br /&gt;
&lt;br /&gt;
Biocon is also developing fully human antibodies BVX 10 and BVX-20 with a US antibody technology partner, Vaccinex. The partnership was initiated in 2004. BVX 10 targets TNF (Tumor Necrosis Factor) which is expressed at high levels in patients suffering from rheumatoid arthritis. Biocon&#039;s strategic partnership with Vaccinex allows access to their proprietary human antibody platform technology, thereby providing a strong IP protection to Biocon&#039;s antibody pipeline.,&amp;lt;ref name=&amp;quot;ref1&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Biocon and Abraxis===&lt;br /&gt;
&lt;br /&gt;
In 2007, Biocon and Abraxis BioScience, Inc. entered into an agreement which helped Biocon out-license the rights to develop and market a biosimilar version of GCSF (Granulocyte Colony-Stimulating Factor) to North American and European markets.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Biocon and Sandoz ===&lt;br /&gt;
In January 2018, [[Sandoz]] (a [[Novartis]] division) announced a global partnership with Biocon to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide. .&amp;lt;ref&amp;gt;{{Cite web|url=https://www.novartis.com/news/media-releases/sandoz-announces-exclusive-global-collaboration-biocon-next-generation-biosimilars|title=Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars {{!}} Novartis|website=Novartis|language=en|access-date=8 February 2018}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Biocon technology==&lt;br /&gt;
&lt;br /&gt;
Biocon&#039;s manufacturing facilities are located at two sites in [[Bangalore]].&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Research &amp;amp; development capabilities ==&lt;br /&gt;
Biocon&#039;s [[R&amp;amp;D]] focuses on the entire drug development pathway – from process development to non-clinical and clinical research.&amp;lt;ref name=&amp;quot;ref12&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Products==&lt;br /&gt;
&lt;br /&gt;
Biocon offers 36 brands of products across the four therapeutic divisions of [[diabetes|diabetology]], [[nephrology]], [[oncology]], and [[cardiology]].&amp;lt;ref name=&amp;quot;ref1&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|refs=&lt;br /&gt;
&lt;br /&gt;
&amp;lt;!-- DO NOT remove comments, see WP:LDRHOW for more info--&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref1&amp;quot;&amp;gt;{{Cite web |url=http://www.biocon.com/docs/AR10-BIOCON.pdf |title=Biocon Annual Report, 2010 |access-date=20 September 2010 |archive-url=https://web.archive.org/web/20101026031837/http://biocon.com/docs/AR10-BIOCON.pdf |archive-date=26 October 2010 |url-status=dead  }}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;!--&amp;lt;ref name=&amp;quot;ref2&amp;quot;&amp;gt;Financial Express, Bangalore, 25 September 2009&amp;lt;/ref&amp;gt;--&amp;gt;&lt;br /&gt;
&amp;lt;!--&amp;lt;ref name=&amp;quot;ref5&amp;quot;&amp;gt;[http://www.moneycontrol.com/news_html_files/news_attachment/2010/Biocon.pdf &amp;quot;Biocon Biopharmaceuticals becomes wholly owned subsidiary&amp;quot;], Moneycontrol.com, 6 April 2010&amp;lt;/ref&amp;gt;--&amp;gt;&lt;br /&gt;
&amp;lt;!-- &amp;lt;ref name=&amp;quot;ref6&amp;quot;&amp;gt;Biotech Bonanza, India Today, 9 August 2004  (http://www.avesthagen.com/press/it.html)&amp;lt;/ref&amp;gt; --&amp;gt;&lt;br /&gt;
&amp;lt;!-- not used &amp;lt;ref name=&amp;quot;ref7&amp;quot;&amp;gt;[http://www.hindu.com/mp/2010/04/27/bangindx.htm], The Hindu, Metro Plus, 27 April 2010 {{Webarchive|url=https://web.archive.org/web/20100502034816/http://www.hindu.com/mp/2010/04/27/bangindx.htm |date=2 May 2010 }}&amp;lt;/ref&amp;gt;--&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref8&amp;quot;&amp;gt;Kiran Mazumdar-Shaw, CMD, Biocon Ltd, [http://www.outlookmoney.com/article.aspx?88528 ‘Biotech Is Not for Punters’], Outlook Money, 15 July 2004&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;!--&amp;lt;ref name=&amp;quot;ref10&amp;quot;&amp;gt;Economic Times, 18 September 2006&amp;lt;/ref&amp;gt;--&amp;gt;&lt;br /&gt;
&amp;lt;!--&amp;lt;ref name=&amp;quot;ref11&amp;quot;&amp;gt;[http://www.technologyreview.in/biomedicine/23610/ &amp;quot;Biocon Injects Innovation Gene&amp;quot;] {{Webarchive|url=https://web.archive.org/web/20110717165453/http://www.technologyreview.in/biomedicine/23610/ |date=17 July 2011 }}, Technology Review, October 2009&amp;lt;/ref&amp;gt;--&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref12&amp;quot;&amp;gt;Biocon Website ({{cite web |url=http://biocon.com/ |title=Archived copy |access-date=3 August 2014 |url-status=dead |archive-url=https://web.archive.org/web/20140807042606/http://www.biocon.com/ |archive-date=7 August 2014 }})&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref13&amp;quot;&amp;gt;Nature Reviews Drug Discovery, July 2010&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref14&amp;quot;&amp;gt;Biospectrum India Friday, 11 July 2008&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref15&amp;quot;&amp;gt;Kiran Mazumdar Shaw, India&#039;s fermentation queen, 30 August 2001&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref16&amp;quot;&amp;gt;[https://www.nytimes.com/2003/08/16/world/the-saturday-profile-how-india-s-mother-of-invention-built-an-industry.html &amp;quot;How India&#039;s Mother of Invention Built an Industry&amp;quot;], 16 August 2003&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref17&amp;quot;&amp;gt;Time, 29 April 2010&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref18&amp;quot;&amp;gt;The World&#039;s 100 Most Powerful Women, Forbes, 19 August 2009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref19&amp;quot;&amp;gt;FT top 50 women in world business, Financial Times, 25 September 2009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;!--&amp;lt;ref name=&amp;quot;ref20&amp;quot;&amp;gt;India’s biotech future, Kiran Mazumdar-Shaw, The Hindu, 15 August 2007&amp;lt;/ref&amp;gt;--&amp;gt;&lt;br /&gt;
&amp;lt;ref name=&amp;quot;ref21&amp;quot;&amp;gt;The Hindu, 12 May 2009&amp;lt;/ref&amp;gt;&lt;br /&gt;
&amp;lt;!-- &amp;lt;ref name=&amp;quot;ref24&amp;quot;&amp;gt;Data shows declining productivity in drug R&amp;amp;D, Reuters, 27 June 2010&amp;lt;/ref&amp;gt; --&amp;gt;&lt;br /&gt;
&amp;lt;!-- &amp;lt;ref name=&amp;quot;ref25&amp;quot;&amp;gt;The Pharmerging Future, IMS Health, June 2009&amp;lt;/ref&amp;gt; --&amp;gt;&lt;br /&gt;
&amp;lt;!-- &amp;lt;ref name=&amp;quot;ref26&amp;quot;&amp;gt;Biocon, IATRICa to co-develop drugs, Business Standard, Bangalore, 17 January 2008&amp;lt;/ref&amp;gt; --&amp;gt;&lt;br /&gt;
}}&lt;br /&gt;
{{Commons category|Biocon}}&lt;br /&gt;
&lt;br /&gt;
{{Nifty 200 companies}}&lt;br /&gt;
{{Bangalore topics}}&lt;br /&gt;
{{Authority control}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Biotechnology companies of India]]&lt;br /&gt;
[[Category:Pharmaceutical companies established in 1978]]&lt;br /&gt;
[[Category:Pharmaceutical companies of India]]&lt;br /&gt;
[[Category:Companies listed on the Bombay Stock Exchange]]&lt;br /&gt;
[[Category:Manufacturing companies based in Bangalore]]&lt;br /&gt;
[[Category:Biotechnology companies established in 1978]]&lt;br /&gt;
[[Category:Indian companies established in 1978]]&lt;br /&gt;
[[Category:Indian brands]]&lt;br /&gt;
[[Category:1978 establishments in Karnataka]]&lt;/div&gt;</summary>
		<author><name>2405:201:D002:39CC:CCB0:C992:6EB7:61C</name></author>
	</entry>
	<entry>
		<id>https://indianpedia.org/index.php?title=InMobi&amp;diff=123104</id>
		<title>InMobi</title>
		<link rel="alternate" type="text/html" href="https://indianpedia.org/index.php?title=InMobi&amp;diff=123104"/>
		<updated>2021-07-05T07:40:11Z</updated>

		<summary type="html">&lt;p&gt;2405:201:D002:39CC:CCB0:C992:6EB7:61C: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{{Short description|Indian multinational technology company}}&lt;br /&gt;
{{Use dmy dates|date=September 2016}}&lt;br /&gt;
{{Use Indian English|date=September 2016}}&lt;br /&gt;
{{Infobox company&lt;br /&gt;
| name = InMobi&lt;br /&gt;
| logo = InMobi logo.svg&lt;br /&gt;
| former_name = mKhoj&lt;br /&gt;
| type = [[Private company|Private]]&lt;br /&gt;
| founded = {{Start date and age|2007}} &amp;lt;ref&amp;gt;{{Cite web|url=https://www.techinasia.com/inmobi-naveen-tewari-founding-story|title=Tech in Asia - Connecting Asia&#039;s startup ecosystem|website=www.techinasia.com}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| founder = {{Unbulleted list|[[Naveen Tewari]]|Mohit Saxena|Amit Gupta|Abhay Singhal}}&lt;br /&gt;
&amp;lt;ref&amp;gt;{{Cite web|url=https://www.zaubacorp.com/company/INMOBI-TECHNOLOGY-SERVICES-PRIVATE-LIMITED/U72900KA2011PTC060216|title=INMOBI TECHNOLOGY SERVICES PRIVATE LIMITED - Company, directors and contact details &amp;amp;#124; Zauba Corp|website=www.zaubacorp.com}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;https://www.crunchbase.com/organization/inmobi#/entity&amp;lt;/ref&amp;gt;&lt;br /&gt;
| area_served = Worldwide&lt;br /&gt;
| key_people = {{plainlist|&lt;br /&gt;
*[[Naveen Tewari]] ([[CEO]])&lt;br /&gt;
*Piyush Shah ([[Chief Product Officer|CPO]])&lt;br /&gt;
*Mark Steifman ([[CFO]])&lt;br /&gt;
}}&lt;br /&gt;
| industry = {{plainlist|&lt;br /&gt;
*[[Internet]]&lt;br /&gt;
*[[Digital marketing]]&lt;br /&gt;
*[[Social networking service]]}}&lt;br /&gt;
| num_employees = 1,500&amp;lt;ref&amp;gt;{{Cite web|url=https://economictimes.indiatimes.com/small-biz/startups/inmobi-grapples-with-senior-mid-level-attrition-amid-concerns-about-future/articleshow/52441131.cms|title=InMobi grapples with senior, mid-level attrition amid concerns about future|first1=Anirban|last1=Sen|first2=Aditi|last2=Shrivastava|via=The Economic Times}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
| location_city = [[Bangalore]], [[Karnataka]], India&lt;br /&gt;
| products = {{Unbulleted list|[[Glance (company)|Glance]]|[[Roposo]]|TruFactor}}&lt;br /&gt;
| homepage = {{url|https://www.inmobi.com/|inmobi.com}}&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;InMobi&#039;&#039;&#039; is an Indian [[multinational corporation|multinational]] [[mobile advertising]] technology company, based in [[Bangalore]], [[Karnataka]].&amp;lt;ref name=&amp;quot;VentureBeat&amp;quot;&amp;gt;{{Cite news|url=https://venturebeat.com/2018/06/26/inmobi-and-microsoft-partner-on-cloud-based-mobile-enterprise-marketing-platform/|title=InMobi and Microsoft partner on cloud-based mobile enterprise marketing platform|date=2018-06-26|work=VentureBeat|access-date=2018-08-23|language=en-US}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;www.ETtech.com&amp;quot;&amp;gt;{{Cite web|url=https://tech.economictimes.indiatimes.com/news/corporate/inmobi-partners-microsoft-to-offer-marketing-solutions-to-enterprises/64750874|title=InMobi partners Microsoft to offer marketing solutions to enterprises - ETtech|last=www.ETtech.com|website=ETtech.com|language=en|access-date=2018-08-23}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Chatterjee&amp;quot;&amp;gt;{{Cite news|url=https://www.reuters.com/article/us-inmobi-microsoft/microsoft-inmobi-collaborate-to-offer-marketing-capabilities-to-enterprise-customers-idUSKBN1JM118|title=Microsoft, InMobi collaborate to offer marketing capabilities to...|last=Chatterjee|first=Laharee|work=U.S.|access-date=2018-08-23|language=en-US}}&amp;lt;/ref&amp;gt; Its mobile-first platform allows brands, developers and publishers to engage consumers through contextual mobile advertising.&amp;lt;ref name=&amp;quot;:0&amp;quot;&amp;gt;{{Cite news|url=http://www.firstpost.com/business/why-did-inmobi-succeed-it-didnt-copy-everything-rivals-did-explains-ceo-naveen-tewari-2656766.html|title=Why did InMobi succeed? It did things differently to compete, explains CEO Naveen Tewari|date=2016-03-07|newspaper=Firstpost|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
The company was founded in 2007 under the name mKhoj by [[Naveen Tewari]], Mohit Saxena, Amit Gupta and Abhay Singhal.&amp;lt;ref&amp;gt;{{Cite news|url=http://economictimes.indiatimes.com/small-biz/startups/inmobis-naveen-tewari-on-the-benefits-of-having-cofounders-who-are-different-yet-similar/articleshow/49210449.cms|title=InMobi&#039;s Naveen Tewari on the benefits of having cofounders &amp;quot;who are different yet similar&amp;quot;|newspaper=The Economic Times|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In 2008, it was enhanced from [[SMS]]-based services to mobile advertising and rebranded as &#039;&#039;&#039;InMobi&#039;&#039;&#039;. In 2011, InMobi became the first Indian [[List of unicorn startup companies|unicorn startup company]].&amp;lt;ref&amp;gt;{{Cite web|url=https://www.thehindubusinessline.com/specials/emerging-entrepreneurs/inmobi-the-journey-of-indias-first-unicorn/article26570570.ece|title=InMobi: The journey of India&#039;s first unicorn|first=N.|last=Ramakrishnan|website=@businessline}}&amp;lt;/ref&amp;gt; InMobi has 22 offices in 12 countries across 5 continents and employs around 1,500 people.&amp;lt;ref name=&amp;quot;Pandya-Wagh&amp;quot;&amp;gt;{{Cite news|url=https://www.bbc.com/news/business-34539191|title=India&#039;s global ad giant taking on Google and Facebook|last=Pandya-Wagh|first=Kinjal|date=2015-10-20|newspaper=BBC News|language=en-GB|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite news|url=http://m.firstpost.com/business/google-looking-buy-indian-startup-inmobi-beef-advertising-platform-2147265.html|title=Is Google looking to buy Indian startup InMobi to improve its advertising platform?|date=2015-03-11|newspaper=Firstpost|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The company is backed by [[Soft Bank]], [[Kleiner Perkins Caufield &amp;amp; Byers]] and [[Ram Shriram]]&#039;s Sherpalo Ventures.&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&amp;lt;ref&amp;gt;{{Cite news|url=http://www.thehindu.com/business/Industry/InMobi-to-pay-950000-for-deceptively-tracking-consumers%E2%80%99-locations/article14397006.ece|title=InMobi to pay $950,000 for deceptively tracking consumers&#039; locations|last=Abrar|first=Peerzada|newspaper=The Hindu|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; InMobi has raised a total of US$215.6 million in three rounds of funding – US$0.5 million in 2007, US$7.1 million in Series A funding in 2008, US$8 million in Series B funding in 2010, US$200 million in Series C funding in 2011.&amp;lt;ref name=&amp;quot;:0&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
InMobi started in 2007, when it was known as &#039;&#039;mKhoj&#039;&#039; (mobile khoj), providing SMS-based [[Web search engine|search engine]] services.&amp;lt;ref name=&amp;quot;Pandya-Wagh&amp;quot;/&amp;gt; Started by the four founders out of a residential apartment in Bangalore, it has since grown into one of [[India]]&#039;s first [[Unicorn (finance)|unicorn companies]].&amp;lt;ref&amp;gt;{{Cite news|url=https://qz.com/287978/these-early-offices-of-indias-hottest-startups-show-how-far-they-have-come/|title=These early offices of India&#039;s hottest startups show how far they have come|last=Madhok|first=Diksha|newspaper=Quartz|access-date=2017-02-07|language=en-US}}&amp;lt;/ref&amp;gt; The founders later felt the need to rebrand to InMobi as the company shifted focus from mobile search to [[mobile advertising]]. &amp;quot;InMobi&amp;quot; was also thought to be easier to pronounce in English as compared to mKhoj – which is a derivative of the [[Hindi]] word for &amp;quot;search&amp;quot;.&amp;lt;ref&amp;gt;{{Cite web|url=https://techcrunch.com/2009/08/05/mobile-ad-network-mkhoj-rebrands-as-inmobi-eyes-expansion-in-europe/|title=Mobile Ad Network m Khoj Rebrands As InMobi, Eyes Expansion In Europe|last=Wauters|first=Robin|website=TechCrunch|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; The company initially operated in emerging markets in [[Asia]] and [[Africa]], before expanding to the US in 2009.&amp;lt;ref&amp;gt;{{Cite news|url=http://knowledge.wharton.upenn.edu/article/inmobis-naveen-tewari-mobile-internet-will-be-the-largest-medium-ever/|title=InMobi&#039;s Naveen Tewari: Mobile Internet Will Be the Largest Medium Ever - Knowledge@Wharton|newspaper=Knowledge@Wharton|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Financing==&lt;br /&gt;
The first round of funding of US$0.5 million InMobi (then mKhoj) was from Mumbai Angels in August 2006. After rebranding the company from mKhoj to InMobi, they received Series A funding of US$7.1 million from [[Kleiner Perkins Caufield &amp;amp; Byers]] in 2008, and Series B funding to the tune of US$8 million in 2010.&amp;lt;ref name=&amp;quot;businesstoday.in&amp;quot;&amp;gt;{{Cite web|url=http://www.businesstoday.in/magazine/corporate/inmobi-is-finding-it-difficult-to-raise-funds/story/235887.html|title=InMobi&#039;s Trials and Tribulations- Business News|website=www.businesstoday.in|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In 2011, the start-up raised US$200 million from [[Soft Bank|Softbank]]. The investment was doled out in two tranches — US$100 million in 2011 and the rest in 2012.&amp;lt;ref&amp;gt;{{Cite web|url=http://mashable.com/2011/09/15/inmobi-raises-200m/|title=Mobile Ad Network InMobi Raises $200 Million|last=Wasserman|first=Todd|website=Mashable|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
=== Rounds of funding and financing ===&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
!Investors&lt;br /&gt;
!Funding Round&lt;br /&gt;
!Amount &lt;br /&gt;
!Year&lt;br /&gt;
|-&lt;br /&gt;
|Mumbai Angels&lt;br /&gt;
|Angel Funding&lt;br /&gt;
|$500,000&lt;br /&gt;
|2007 &lt;br /&gt;
|-&lt;br /&gt;
|Kleiner Perkins Caufield &amp;amp; Byers and  Sherpalo Ventures&lt;br /&gt;
|Series A&lt;br /&gt;
|$7,100,000&lt;br /&gt;
|2008&lt;br /&gt;
|-&lt;br /&gt;
|Kleiner Perkins Caufield &amp;amp; Byers and  Sherpalo Ventures&lt;br /&gt;
|Series B&lt;br /&gt;
|$8,000,000&lt;br /&gt;
|2010&lt;br /&gt;
|-&lt;br /&gt;
|Softbank&lt;br /&gt;
|Series C&lt;br /&gt;
|$200,000,000&lt;br /&gt;
|2011&lt;br /&gt;
|-&lt;br /&gt;
|Softbank&lt;br /&gt;
|Venture&lt;br /&gt;
|$5,000,000&lt;br /&gt;
|2014&lt;br /&gt;
|-&lt;br /&gt;
|Tennenbaum Capital Partners&lt;br /&gt;
|Debt Financing &lt;br /&gt;
|$100,000,000&lt;br /&gt;
|2015&lt;br /&gt;
|}&lt;br /&gt;
Source - &amp;lt;ref&amp;gt;{{Cite web|url=https://www.crunchbase.com/organization/inmobi/funding-rounds|title=InMobi - Funding Rounds {{!}} crunchbase|website=www.crunchbase.com|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Acquisitions and partnerships ==&lt;br /&gt;
* In August 2011, InMobi acquired US-based mobile advertising solutions{{buzzword inline|date=December 2020}} provider Sprout, which was backed by [[Polaris Partners]]. Sprout, which provided the platform for creating [[HTML5]] rich media advertising, was renamed InMobi Studio in 2012.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.afaqs.com/news/story/31305_InMobi-acquires-Sprout|title=InMobi acquires Sprout|website=www.afaqs.com|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite web|url=https://www.nextbigwhat.com/html5-ad-platform-sprout-rebranded-to-inmobi-studio-297/|title=InMobi rebrands HTML5 ad platform Sprout to InMobi Studio|website=www.nextbigwhat.com|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* InMobi had partnered with Amobee, end-to-end mobile advertising solutions{{buzzword inline|date=December 2020}} and services provider for a span of three years during which the company ran campaigns via InMobi&#039;s ad network.&amp;lt;ref&amp;gt;{{Cite web|url=https://techcrunch.com/2011/05/11/inmobi-signs-multi-million-dollar-mobile-ad-partnership-with-amobee/|title=InMobi signs &amp;quot;multi-million dollar&amp;quot; mobile ad partnership with Amobee|last=O&#039;Hear|first=Steve|website=TechCrunch|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* In July 2012, InMobi acquired MMTG Labs, a San Francisco-based start-up that operates Facebook apps marketplace Appbistro as well as white label app distribution platform AppGalleries. Per [[TechCrunch]], the new platform AppGallery was the reason for InMobi acquisition of MMTG.&amp;lt;ref&amp;gt;{{Cite web|url=https://techcrunch.com/2012/07/12/inmobi-buys-appbistro-appgalleries-mmtg-labs/|title=InMobi Acquires MMTG Labs, The Startup Behind AppBistro And AppGalleries|last=Taylor|first=Colleen|website=TechCrunch|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite web|url=http://www.medianama.com/2012/07/223-inmobi-acquires-appbistro-appgalleries-owner-mmtg-labs/|title=InMobi Acquires Appbistro &amp;amp; AppGalleries Owner MMTG Labs|last=SN|first=Vikas|date=2012-07-13|website=MediaNama|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;  &lt;br /&gt;
* Post-MMTG acquisition, InMobi acquired Metaflow Solutions, a mobile app management and distribution company in the same year. This provides InMobi another platform to reach out to independent app developers and publishers.&amp;lt;ref&amp;gt;{{Cite news|url=http://articles.economictimes.indiatimes.com/2012-07-31/news/32961713_1_naveen-tewari-inmobi-mobile-internet-space|title=InMobi acquires UK-based Metaflow Solutions - The Economic Times|newspaper=The Economic Times|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
* In September 2015, InMobi entered a [[monetization|monetisation]] partnership with China-based [[APUS Group|APUS group]], which allows users to customise their android screens. The partnership provides the company access to an estimated 500 million users in China as well as exclusive access to all APUS users in [[India]].&amp;lt;ref&amp;gt;{{Cite web|url=http://www.vccircle.com/news/technology/2015/09/29/inmobi-raises-100m-tennenbaum-others|title=InMobi raises $100M from Tennenbaum, others|website=www.vccircle.com|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite news|url=https://www.forbes.com/sites/abehal/2015/11/26/indias-inmobi-is-giving-facebook-and-google-a-run-for-their-money/#400c0549795d|title=India&#039;s InMobi Is Giving Facebook And Google A Run For Their Money|last=Behal|first=Ambika|newspaper=Forbes|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* In October 2016, InMobi partnered with Moat, a New York-based [[Software as a service|SaaS]] analytics company to offer advertisers mobile video measurement and currency measurement through InMobi Exchange – which provides media buyers an extensive and diverse set of engaging mobile ad experiences through mobile native and mobile video formats and the InMobi network.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.financial-news.co.uk/37916/2016/10/inmobi-moat-to-allow-brands-to-transact-on-viewability/|title=InMobi, Moat to allow brands to transact on Viewability - Financial News|website=www.financial-news.co.uk|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* InMobi partnered with [[Integral Ad Science]] in December 2016 to launch their Media Rating Council-accredited open source [[Software development kit|SDK]] code for mobile ad viewability.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.adageindia.in/Integral-Ad-Science-Partners-with-Google-Others-for-Open-Source-Viewability/articleshow/55884361.cms|title=Ad Age Homepage - AdAge|website=www.adageindia.in|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
* In December 2016, InMobi also partnered exclusively with US-based Tapjoy, a mobile ads and app monetisation company with around 4 [[crore]] (40 million) unique users in [[India]].&amp;lt;ref&amp;gt;{{Cite news|url=http://bwdisrupt.businessworld.in/article/InMobi-And-Tapjoy-Forge-Exclusive-Partnership-in-India/12-12-2016-109618/|title=InMobi And Tapjoy Forge Exclusive Partnership in India|last=Bureau|first=BW Online|newspaper=BW Disrupt|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* In Jan 2018, InMobi acquired Los Angeles based Aerserv for US$90 Million in cash and stock to create the world&#039;s largest programmatic video platform for mobile publishers; making it InMobi&#039;s fifth and largest acquisition till date.&amp;lt;ref&amp;gt;{{Cite news|url=https://qz.com/1175121/inmobi-an-indian-unicorn-is-going-global-in-search-of-technology-and-talent/|title=An Indian unicorn is going global in search of technology and talent|last=Bhattacharya|first=Ananya|work=Quartz|access-date=2018-01-17|language=en-US}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;{{Cite news|url=https://timesofindia.indiatimes.com/companies/inmobi-acquires-us-based-aerserv-for-90-million/articleshow/62447774.cms|title=InMobi acquires US-based AerServ for $90 million - Times of India|work=The Times of India|access-date=2018-01-17}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*In June 2018, [[Microsoft|Microsoft Corp]] announced its global partnership with InMobi to enable new-age CMOs in make the shift from digital to mobile marketing.&amp;lt;ref name=&amp;quot;VentureBeat&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;Chatterjee&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;www.ETtech.com&amp;quot;/&amp;gt;&lt;br /&gt;
*In November 2019, InMobi&#039;s [[Glance (company)|Glance]]&amp;lt;ref&amp;gt;{{Cite news|url=https://www.forbesindia.com/article/leaderboard/inmobi-wants-to-glue-your-attention-to-your-lock-screen/53095/1|title=InMobi wants to glue your attention to your lock screen|date=2019-04-17|newspaper= Forbesindia.com- forbes india business news, share market investment, India&#039;s richest people, startups|language=en-US}}&amp;lt;/ref&amp;gt; (the mobile content platform and part of the InMobi Group) acquires short video content platform [[Roposo]].&amp;lt;ref&amp;gt;{{Cite web|url=https://inshorts.com/en/news/indias-1st-unicorn-inmobis-glance-buys-iitians-video-app-roposo-1574739188398|title=India&#039;s 1st unicorn InMobi&#039;s Glance buys IITians&#039; video app Roposo|website=Inshorts - Stay Informed|language=en|access-date=2019-11-26}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*In December 2020, InMobi&#039;s Glance achieved unicorn status after US$145 funding from Google and existing investor Mithril Capital.[https://inc42.com/buzz/glance-turns-unicorn-in-under-two-years-with-funding-from-google/]&lt;br /&gt;
&lt;br /&gt;
== Mobile advertising ==&lt;br /&gt;
The primary focus of InMobi has been on mobile advertising. The company&#039;s platform aims to bring together publishers and advertisers to provide relevant, personalised and [[Contextual advertising|contextual advertisements]] to a user visiting the mobile app or website.&amp;lt;ref name=&amp;quot;:0&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Since the company&#039;s switch from an SMS-based search engine to an advertising platform, they have made several product announcements. The company started with simple text-based ads and has moved to include other ad formats such as video and native ads, including conventional ad formats such as interstitial and banner ads. The company also provides a [[Software development kit|Software Development Kit]] (SDK) for mobile app creators who wish to integrate InMobi&#039;s advertising within their app.&amp;lt;ref&amp;gt;{{Cite news|url=http://www.marketingdive.com/news/iab-tech-lab-assumes-governance-of-open-source-in-app-measurability-tool/433548/|title=IAB Tech Lab assumes governance of open-source in-app measurability tool|newspaper=Marketing Dive|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In 2014, InMobi launched their [[native advertising]] and [[Video advertising|interactive video advertising]] platforms.&amp;lt;ref name=&amp;quot;:1&amp;quot;&amp;gt;{{Cite web|url=https://techcrunch.com/2014/02/10/inmobi-launches-interactive-video-ad-platform-to-help-advertisers-boost-sales-on-mobile/|title=InMobi Launches Interactive Video Ad Platform To Help Advertisers Boost Sales On Mobile|last=Mishra|first=Pankaj|website=TechCrunch|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
InMobi has tied up with over 30,000 app developers, across verticals of gaming, social, news, utility, entertainment among others to help them monetize their apps using mobile advertising.&amp;lt;ref&amp;gt;{{Cite news|url=http://economictimes.indiatimes.com/industry/services/advertising/inmobi-ties-up-with-chinas-apus-for-global-growth/articleshow/48988717.cms|title=InMobi ties up with China&#039;s APUS for global growth - The Economic Times|newspaper=The Economic Times|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Native advertising ==&lt;br /&gt;
InMobi launched their native advertising platform in 2014. [[Native advertising]] mimics the environment in which the ad is displayed thereby making it less intrusive to the end consumer.&lt;br /&gt;
&lt;br /&gt;
Several advertising players had been increasing their focus on native ads to preserve the user experience on publishers’ websites and mobile apps by mimicking the environment in which they&#039;re displayed. This form of advertising also curtails the adoption of ad blockers as the ads are unobtrusive.&amp;lt;ref name=&amp;quot;Mishra&amp;quot;&amp;gt;{{Cite web|url=https://techcrunch.com/2014/04/29/inmobi-launches-native-ad-platform-to-woo-publishers-looking-beyond-facebook-google/|title=InMobi Launches Native Ad Platform To Woo Publishers Looking Beyond Facebook, Google|last=Mishra|first=Pankaj|website=TechCrunch|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
InMobi features 80 of the top 100 AdAge brands on their network, through which it provides a huge database for publishers to use their native advertising platform to monetise users.&amp;lt;ref&amp;gt;{{Cite news|url=http://www.businessofapps.com/top-app-advertising-sdks-2015/|title=Top App Advertising SDKs 2015|date=2015-09-21|newspaper=Business of Apps|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Discovery-commerce, re-marketing and Miip ==&lt;br /&gt;
InMobi launched a new platform called Miip in 2015. The platform brought together advertisers and publishers in a bid to spark excitement among online shoppers. It also enabled them to discover new products using the concept of re-marketing.&amp;lt;ref&amp;gt;{{Cite news|url=http://www.business-standard.com/article/companies/inmobi-launches-content-discovery-ad-platform-miip-115071500160_1.html|title=InMobi launches content discovery ad platform Miip|last=Reporter|first=B. S.|date=2015-07-15|newspaper=Business Standard India|access-date=2017-02-07}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The remarketing platform enables app developers and marketers to retarget existing users across InMobi&#039;s global ad network and exchange by implementing a mobile growth strategy across the entire conversion funnel. The remarketing platform helps advertisers nudge users to make their first purchase, re-target existing users to drive incremental sales and re-activate dormant mobile users.&amp;lt;ref&amp;gt;{{Cite web|url=http://www.mediapost.com/publications/article/288279/inmobi-launches-mobile-first-in-app-remarketing-pl.html|title=InMobi Launches Mobile-First In-App Remarketing Platform|website=www.mediapost.com|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; The platform increases in-app conversions by analysis based on in-app behavior, purchase history, and other personalized attributes.&amp;lt;ref&amp;gt;{{Cite news|url=http://bwdisrupt.businessworld.in/article/InMobi-s-Remarketing-Platform-Helps-Indian-eCommerce-Companies-Maximize-Sales-on-Mobile-Channels-/16-06-2016-99280/|title=InMobi s Remarketing Platform Helps Indian eCommerce Companies Maximize Sales on Mobile Channels|last=Bureau|first=BW Online|newspaper=BW Disrupt|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Awards and recognition ==&lt;br /&gt;
* InMobi won the ‘NDTV Indian of the Year&#039; award in 2016&amp;lt;ref&amp;gt;{{Citation|last=NDTV|title=We are in China, taking on the Chinese, says India&#039;s InMobi|date=2016-02-02|url=https://www.youtube.com/watch?v=vzg8vn2k8U8|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
* InMobi was ranked 15th on the ‘World&#039;s Top 50 Innovative Companies 2016’ by Fast Company, a US-based business magazine. InMobi was also the number one company from India on the list ranked at 15th&amp;lt;ref&amp;gt;{{Cite web|url=http://www.livemint.com/Home-Page/IctaEu18B6NhIHRhhn5ovL/Top-50-innovative-companies.html|title=Top 50 innovative companies|last=Mathur|first=Nandita|date=2016-02-17|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
* InMobi was featured amongst The Economic Times ‘India&#039;s best workplaces of 2016’ for workplace culture transformation.&amp;lt;ref&amp;gt;{{Cite news|url=http://economictimes.indiatimes.com/articleshow/53004022.cms|title=India&#039;s best workplaces of 2016: Winners of best companies in workplace culture transformation|newspaper=The Economic Times|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; InMobi was amongst the ‘50 Disruptive companies 2013’ list by MIT Technology Review&amp;lt;ref&amp;gt;{{Citation |url=http://www2.technologyreview.com/tr50/2013/|title=50 Disruptive Companies 2013 - MIT Technology Review|last=Review|first=MIT Technology|newspaper=MIT Technology Review|access-date=2017-02-02}}&amp;lt;/ref&amp;gt; &lt;br /&gt;
* InMobi won the bronze award in the category Enabling Technologies, Location based Advertising by Mobile Marketing Association (MMA), Global Smarties Awards 2015 in partnership with Unilever and Mindshare&amp;lt;ref&amp;gt;{{Cite news|url=http://www.mmaglobal.com/news/mma-unveils-2015-global-smarties-winners-celebrating-exceptional-campaigns-mobile-marketing|title=MMA Unveils 2015 Global Smarties Winners Celebrating Exceptional Campaigns in Mobile Marketing|newspaper=Mobile Marketing Association|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*InMobi named one among Fast Company- The World&#039;s Most Innovative Companies, 2016.&amp;lt;ref&amp;gt;{{Cite news|url=https://www.fastcompany.com/most-innovative-companies/2016/sectors/india|title=The 2016 Top 10 Most Innovative Companies by Sector: India {{!}} Fast Company|work=Fast Company|access-date=2018-08-23|language=en-US}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*InMobi named on CNBC Disruptor 50 list for 2018.&amp;lt;ref&amp;gt;{{Cite news|url=https://www.cnbc.com/2018/05/22/meet-the-2018-cnbc-disruptor-50-companies.html|title=Meet the 2018 CNBC Disruptor 50 companies|author=CNBC.com staff|date=2018-05-22|work=CNBC|access-date=2018-08-23}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*InMobi named one among Fast Company- The World&#039;s Most Innovative Companies, 2018.&amp;lt;ref&amp;gt;{{Cite news|url=https://www.fastcompany.com/company/inmobi|title=InMobi: Most Innovative Company {{!}} Fast Company|work=Fast Company|access-date=2018-08-23|language=en-US}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
*InMobi named on CNBC Disruptor 50 list for 2019.&amp;lt;ref&amp;gt;{{Cite news|url=https://www.cnbc.com/2019/05/15/meet-the-2019-cnbc-disruptor-50-companies.html|title=Meet the 2019 CNBC Disruptor 50 companies}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
== Criticism ==&lt;br /&gt;
According to sources, InMobi laid off approximately 10 per cent of its workforce in April 2016, due to the company reeling under losses of US$45.5 million in 2014-15 and US$40.91 million in 2015–16 in a bid to show profitability.&amp;lt;ref name=&amp;quot;businesstoday.in&amp;quot;/&amp;gt; The company also saw major attrition in their senior management during this phase.&amp;lt;ref&amp;gt;{{Cite news|url=http://www.thehindu.com/business/Industry/layoffs-at-iconic-mobile-ad-startup-inmobi/article8447567.ece|title=Layoffs at iconic mobile ad start-up InMobi|last=Chandran|first=Peerzada Abrar, Pradeesh|newspaper=The Hindu|language=en|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
InMobi has refuted the claims, by stating that they added 184 full employees in 2016 and their voluntary attrition rates are lower than the industry average with 80% of the executive team at InMobi has an average tenure of more than four years.&amp;lt;ref&amp;gt;{{Cite news|url=http://techcircle.vccircle.com/2016/12/30/flashback-2016-inmobi-grapples-with-eroding-confidence-losses/|title=Flashback 2016: InMobi grapples with top-level exits, losses|date=2016-12-30|newspaper=Techcircle.in - India startups, internet, mobile, e-commerce, software, online businesses, technology, venture capital, angel, seed funding|language=en-US|access-date=2017-02-02}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|refs=https://www.ftc.gov/news-events/press-releases/2016/06/mobile-advertising-network-inmobi-settles-ftc-charges-it-tracked|colwidth=30em}}&lt;br /&gt;
&lt;br /&gt;
==External links==&lt;br /&gt;
*{{url|www.inmobi.com|Official site}}&lt;br /&gt;
&lt;br /&gt;
{{SoftBank}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Indian companies established in 2007]]&lt;br /&gt;
[[Category:Software companies of India]]&lt;br /&gt;
[[Category:Outsourcing companies]]&lt;br /&gt;
[[Category:Companies based in Bangalore]]&lt;br /&gt;
[[Category:Softbank portfolio companies]]&lt;br /&gt;
[[Category:2007 establishments in Karnataka]]&lt;/div&gt;</summary>
		<author><name>2405:201:D002:39CC:CCB0:C992:6EB7:61C</name></author>
	</entry>
</feed>